Strong personal care and hospice growth, improving home health, and low leverage support continued expansion.
| Quarter | Q2 FY26 |
|---|---|
| Call date | 2026-08-03 |
| Length | 59 minutes |
| EPS | $1.56 |
| EPS consensus | $1.51 |
| Revenue | $377.4M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q4 FY25 · Q2 FY25
All ADUS earnings · Back to ADUS overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.